(File photo)
NEW DELHI: The country’s top drug regulator has allowed Mumbai-based Sun Pharmaceutical to conduct clinical trial for the first phytopharmaceutical (plant based) drug AQCH to see if it can treat Covid-19 patients. Results of the trial are expected by October 2020.
AQCH, which is being developed for dengue, has shown broad antiviral effect in in vitro studies, prompting Sun Pharma to start Phase II clinical trials to test the drug as a potential treatment option for Covid-19.
Clinical trial will be conducted across 12 centres in India in 210 patients. The treatment